+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Memphasys Ltd (MEM) - Product Pipeline Analysis, 2018 Update

  • PDF Icon

    Company Profile

  • 25 Pages
  • October 2018
  • GlobalData
  • ID: 4455838
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd, is a bio-separations company that develops and commercializes membrane technology solutions. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen sample using electrophoresis and specialist membranes for the use in fertility treatments, including IVF for humans, artificial reproductive techniques for animals; and hydrogel membranes. It serves therapeutic plasma, IVF clinical, and research consumables markets. Memphasys also develops polymer membrane separation technology using polyacrylamide hydrogel membranes with electrophoresis. The company has operations in Australia, Singapore and the US. Memphasys is headquartered in Sydney, New South Wales, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

  • The report analyzes all pipeline products in development for the company Memphasys Ltd

  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

  • The report provides detailed description of products in development, technical specification and functions

  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.


Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

  • To formulate effective Research & Development strategies

  • Develop market-entry and market expansion strategies

  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Memphasys Ltd Company Overview
Memphasys Ltd Company Snapshot
Memphasys Ltd Pipeline Products and Ongoing Clinical Trials Overview
Memphasys Ltd – Pipeline Analysis Overview
Memphasys Ltd - Key Facts
Memphasys Ltd - Major Products and Services
Memphasys Ltd Pipeline Products by Development Stage
Memphasys Ltd Pipeline Products Overview
Felix
Felix Product Overview
Second Generation Clinical SpermSep Device
Second Generation Clinical SpermSep Device Product Overview
SpermSep200
SpermSep200 Product Overview
Memphasys Ltd - Key Competitors
Memphasys Ltd - Key Employees
Memphasys Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Memphasys Ltd, Recent Developments
Jul 19, 2018: Attendance at ESHRE Conference in Spain generates interest from selected, pre-eminent IVF clinics to conduct in-vitro studies with Felix device to demonstrate sperm separation efficacy
Jun 07, 2018: Memphasys Appoints Marjan Mikel as Non-Executive Director
May 03, 2018: Felix Device Development On-Track
Jun 29, 2017: Memphasys: Update On Spermsep Development
May 18, 2017: Memphasys Provides Update On Next Stage Of SPERMSEP Development
Aug 10, 2015: Start Of In-Vitro Clinical Trial At Monash IVF
Nov 29, 2013: NuSep Board Changes
Oct 29, 2013: NuSep Announces Board Changes
Sep 06, 2013: NuSep Presents at Bioplasma Conference
Aug 30, 2013: NuSep announces 30 June 2013 Full Year Results
Appendix
Methodology
About
Contact Us
Disclaimer
List of Tables
Memphasys Ltd Pipeline Products and Ongoing Clinical Trials Overview
Memphasys Ltd Pipeline Products by Equipment Type
Memphasys Ltd Pipeline Products by Indication
Memphasys Ltd, Key Facts
Memphasys Ltd, Major Products and Services
Memphasys Ltd Number of Pipeline Products by Development Stage
Memphasys Ltd Pipeline Products Summary by Development Stage
Felix - Product Status
Felix - Product Description
Second Generation Clinical SpermSep Device - Product Status
Second Generation Clinical SpermSep Device - Product Description
SpermSep200 - Product Status
SpermSep200 - Product Description
Memphasys Ltd, Key Employees
Glossary
List of Figures
Memphasys Ltd Pipeline Products by Equipment Type
Memphasys Ltd Pipeline Products by Development Stage 8

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Factor Therapeutics Ltd

  • Regeneus Ltd

  • LBT Innovations Limited